Margaret A. Alexander

This profile gathers the share dealings of Margaret A. Alexander in Ovid Therapeutics Inc. In total, 4 filings cover trades dated from 27 January 2025 to 23 February 2026.

On the open market, the record shows 1 purchase worth €4,749 and 2 sales worth €17k. Sales outweigh purchases by €12k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 1 share grant. In 2026 alone, the filings show no purchases and 1 sale.

On 2 March 2026 came the latest disclosure, an open-market sale for €14k in Ovid Therapeutics Inc. The last insider purchase was made public on 29 January 2025, 628 days ago. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.